FDA expands meningitis vaccine approval
The U.S. Food and Drug Administration has expanded approval for the use of Menactra, a bacterial meningitis vaccine, to children ages 2 to 10.
Menactra was first approved by the FDA in January 2005 for people ages 11 to 55. The vaccine Menomune was previously the only meningococcal vaccine available in the United States for use in children ages 2 and older, the FDA said Thursday in a release.
Both products are manufactured by Sanofi Pasteur Inc. of Swiftwater, Pa.
Meningitis, a serious inflammation of the lining that surrounds the spinal cord and brain, can cause death or permanent brain injury.
Copyright 2007 by United Press International
Citation:
FDA expands meningitis vaccine approval (2007, October 22)
retrieved 18 April 2024
from https://medicalxpress.com/news/2007-10-fda-meningitis-vaccine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
